September 10, 2024 12:39 PM EDTUpdated 01:12 PM
FDA+
Manufacturing

FDA sends warn­ing let­ter to In­di­an drug­mak­er af­ter find­ing glass in in­jec­tions 

Anna Brown

News Reporter

In­di­an gener­ic man­u­fac­tur­er Zy­dus Life­sciences was hit with an FDA warn­ing let­ter on Tues­day af­ter it shipped vi­t­a­min B in­jec­tions con­tain­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

A service from the Financial Times